학술논문
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
Document Type
Article
Author
Source
In The Lancet Oncology February 2017 18(2):212-220
Subject
Language
ISSN
1470-2045